novo nordisk fda semaglutide Seeks Approval For Higher Dose of Wegovy Weight-Loss Shot Article » PBD

The authors found that semaglutide, the active ingredient in the drugs Ozempic for diabetes and Wegovy for weight loss, as well as liraglutide (Saxenda) were associated with a lower risk of worsening mental illness in those with anxiety and depression

While most vision changes are temporary and benign, sustained symptoms could indicate more serious complications like worsening diabetic retinopathy or, rarely, developing NAION

Kidney function may need reassessment when vomiting or diarrhea raises dehydration risk

The class of drugs, known as GLP-1 agonists, have been found to offer dramatic benefits to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause

Consult your regular physician for diagnoses and treatments